Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Hein

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Thrombosis and Haemostasis|August 17, 2023
Plasma Soluble Glycoprotein VI, Platelet Function, Bleeding, and Ischemic Events in Patients Undergoing Elective Percutaneous Coronary InterventionShqipdona Lahu, Kristin Adler, Katharina Mayer, et al.
Thrombosis and Haemostasis|January 30, 2019
Diurnal Variability of On-Treatment Platelet Reactivity in Clopidogrel versus Prasugrel Treated Acute Coronary Syndrome Patients: A Pre-Specified TROPICAL-ACS Sub-StudyMatthias K Freynhofer, Ralph Hein-Rothweiler, Paul M Haller, et al.
Thrombosis and Haemostasis|June 22, 2019
Revacept, a Novel Inhibitor of Platelet Adhesion, in Patients Undergoing Elective PCI-Design and Rationale of the Randomized ISAR-PLASTER TrialStefanie Schüpke, Ralph Hein-Rothweiler, Katharina Mayer, et al.
European Heart Journal. Acute Cardiovascular Care|December 26, 2025
Guided De-escalation of Antiplatelet Treatment in Patients at High Atherothrombotic Risk Presenting With Acute Coronary Syndrome: A Post-Hoc Analysis of the TROPICAL-ACS trialSerdar Farhan, Ralph Hein, Dietmar Trenk, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 20, 2019
Smoking and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients: a substudy from the randomized TROPICAL-ACS trialMartin Orban, Dietmar Trenk, Tobias Geisler, et al.
Thrombosis and Haemostasis|June 22, 2019
Gender and Outcomes following Guided De-Escalation of Antiplatelet Treatment in Acute Coronary Syndrome Patients: The TROPICAL-ACS Gender SubstudyLisa Gross, Danny Kupka, Dietmar Trenk, et al.
Journal of Clinical Medicine|January 8, 2023
Heparin-Induced Thrombocytopenia in Patients Undergoing Venoarterial Extracorporeal Membrane OxygenationEnzo Lüsebrink, Clemens Scherer, Leonhard Binzenhöfer, et al.
International Journal of Cardiology|December 14, 2020
Cardiac allograft vasculopathy: Differences of absolute and relative intimal hyperplasia in children versus adults in optical coherence tomographyMadeleine Orban, Sarah Ulrich, Dominic Dischl, et al.
JAMA Cardiology|March 31, 2021
Efficacy and Safety of Revacept, a Novel Lesion-Directed Competitive Antagonist to Platelet Glycoprotein VI, in Patients Undergoing Elective Percutaneous Coronary Intervention for Stable Ischemic Heart Disease: The Randomized, Double-blind, Placebo-Controlled ISAR-PLASTER Phase 2 TrialKatharina Mayer, Ralph Hein-Rothweiler, Stefanie Schüpke, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Thrombosis and Haemostasis|August 17, 2023
Plasma Soluble Glycoprotein VI, Platelet Function, Bleeding, and Ischemic Events in Patients Undergoing Elective Percutaneous Coronary InterventionShqipdona Lahu, Kristin Adler, Katharina Mayer, et al.
Thrombosis and Haemostasis|January 30, 2019
Diurnal Variability of On-Treatment Platelet Reactivity in Clopidogrel versus Prasugrel Treated Acute Coronary Syndrome Patients: A Pre-Specified TROPICAL-ACS Sub-StudyMatthias K Freynhofer, Ralph Hein-Rothweiler, Paul M Haller, et al.
Thrombosis and Haemostasis|June 22, 2019
Revacept, a Novel Inhibitor of Platelet Adhesion, in Patients Undergoing Elective PCI-Design and Rationale of the Randomized ISAR-PLASTER TrialStefanie Schüpke, Ralph Hein-Rothweiler, Katharina Mayer, et al.
European Heart Journal. Acute Cardiovascular Care|December 26, 2025
Guided De-escalation of Antiplatelet Treatment in Patients at High Atherothrombotic Risk Presenting With Acute Coronary Syndrome: A Post-Hoc Analysis of the TROPICAL-ACS trialSerdar Farhan, Ralph Hein, Dietmar Trenk, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 20, 2019
Smoking and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients: a substudy from the randomized TROPICAL-ACS trialMartin Orban, Dietmar Trenk, Tobias Geisler, et al.
Thrombosis and Haemostasis|June 22, 2019
Gender and Outcomes following Guided De-Escalation of Antiplatelet Treatment in Acute Coronary Syndrome Patients: The TROPICAL-ACS Gender SubstudyLisa Gross, Danny Kupka, Dietmar Trenk, et al.
Journal of Clinical Medicine|January 8, 2023
Heparin-Induced Thrombocytopenia in Patients Undergoing Venoarterial Extracorporeal Membrane OxygenationEnzo Lüsebrink, Clemens Scherer, Leonhard Binzenhöfer, et al.
International Journal of Cardiology|December 14, 2020
Cardiac allograft vasculopathy: Differences of absolute and relative intimal hyperplasia in children versus adults in optical coherence tomographyMadeleine Orban, Sarah Ulrich, Dominic Dischl, et al.
JAMA Cardiology|March 31, 2021
Efficacy and Safety of Revacept, a Novel Lesion-Directed Competitive Antagonist to Platelet Glycoprotein VI, in Patients Undergoing Elective Percutaneous Coronary Intervention for Stable Ischemic Heart Disease: The Randomized, Double-blind, Placebo-Controlled ISAR-PLASTER Phase 2 TrialKatharina Mayer, Ralph Hein-Rothweiler, Stefanie Schüpke, et al.
Pageof 3